Next Article in Journal
TMEM211 Promotes Tumor Progression and Metastasis in Colon Cancer
Previous Article in Journal
Immune Response and Immune Checkpoint Molecules in Patients with Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy: A Review
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Communication

Characterization of Mammary Tumors Arising from MMTV-PyVT Transgenic Mice

1
Department of Surgery, MacKay Memorial Hospital and Mackay Medical College, Taipei 104217, Taiwan
2
Institute of Biomedical Sciences, Mackay Medical College, New Taipei City 252005, Taiwan
3
Department of Medical Research, MacKay Memorial Hospital, Taipei 104217, Taiwan
4
Department of Bioscience Technology, Chung Yuan Christian University, Taoyuan City 320314, Taiwan
*
Author to whom correspondence should be addressed.
Curr. Issues Mol. Biol. 2023, 45(6), 4518-4528; https://doi.org/10.3390/cimb45060286
Submission received: 6 May 2023 / Revised: 20 May 2023 / Accepted: 22 May 2023 / Published: 24 May 2023
(This article belongs to the Topic Animal Models of Human Disease)

Abstract

Among genetically engineered mouse models of breast cancer, MMTV-PyVT is a mouse strain in which the oncogenic polyoma virus middle T antigen is driven by the mouse mammary tumor virus promoter. The aim of the present study was to perform morphologic and genetic analyses of mammary tumors arising from MMTV-PyVT mice. To this end, mammary tumors were obtained at 6, 9, 12, and 16 weeks of age for histology and whole-mount analyses. We conducted whole-exome sequencing to identify constitutional and tumor-specific mutations, and genetic variants were identified using the GRCm38/mm10 mouse reference genome. Using hematoxylin and eosin analysis and whole-mount carmine alum staining, we demonstrated the progressive proliferation and invasion of mammary tumors. Frameshift insertions/deletions (indels) were noted in the Muc4. Mammary tumors showed small indels and nonsynonymous single-nucleotide variants but no somatic structural alterations or copy number variations. In summary, we validated MMTV-PyVT transgenic mice as a multistage model for mammary carcinoma development and progression. Our characterization may be used as a reference for guidance in future research.
Keywords: breast cancer; MMTV-PyVT mice; whole-exome sequencing breast cancer; MMTV-PyVT mice; whole-exome sequencing

Share and Cite

MDPI and ACS Style

Liu, C.-L.; Huang, W.-C.; Cheng, S.-P.; Chen, M.-J.; Lin, C.-H.; Chang, S.-C.; Chang, Y.-C. Characterization of Mammary Tumors Arising from MMTV-PyVT Transgenic Mice. Curr. Issues Mol. Biol. 2023, 45, 4518-4528. https://doi.org/10.3390/cimb45060286

AMA Style

Liu C-L, Huang W-C, Cheng S-P, Chen M-J, Lin C-H, Chang S-C, Chang Y-C. Characterization of Mammary Tumors Arising from MMTV-PyVT Transgenic Mice. Current Issues in Molecular Biology. 2023; 45(6):4518-4528. https://doi.org/10.3390/cimb45060286

Chicago/Turabian Style

Liu, Chien-Liang, Wen-Chien Huang, Shih-Ping Cheng, Ming-Jen Chen, Chi-Hsin Lin, Shao-Chiang Chang, and Yuan-Ching Chang. 2023. "Characterization of Mammary Tumors Arising from MMTV-PyVT Transgenic Mice" Current Issues in Molecular Biology 45, no. 6: 4518-4528. https://doi.org/10.3390/cimb45060286

APA Style

Liu, C.-L., Huang, W.-C., Cheng, S.-P., Chen, M.-J., Lin, C.-H., Chang, S.-C., & Chang, Y.-C. (2023). Characterization of Mammary Tumors Arising from MMTV-PyVT Transgenic Mice. Current Issues in Molecular Biology, 45(6), 4518-4528. https://doi.org/10.3390/cimb45060286

Article Metrics

Back to TopTop